𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem

✍ Scribed by Katsube, Takayuki (author);Yano, Yoshitaka (author);Wajima, Toshihiro (author);Yamano, Yoshinori (author);Takano, Mikihisa (author)


Publisher
John Wiley and Sons Inc.
Year
2010
Tongue
English
Weight
170 KB
Volume
99
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pharmacokinetic/pharmacodynamic modeling
✍ Katsube, Takayuki (author);Yano, Yoshitaka (author);Wajima, Toshihiro (author);Y 📂 Article 📅 2010 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 170 KB

The aim of this study was to obtain information on effective dosage regimens of doripenem by a modeling and simulation approach based on pharmacokinetic (PK)/pharmacodynamic (PD) theory. The PK/PD model we have already developed was modified to explain in vitro bactericidal kinetics of doripenem for

Pharmacokinetic–pharmacodynamic modeling
✍ Takayuki Katsube; Yoshinori Yamano; Yoshitaka Yano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to simulate in vivo bactericidal effects for three carbapenem antibiotics, doripenem (DRPM), meropenem (MEPM)/cilastatin (CS), and imipenem (IPM)/CS, against a Pseudomonas aeruginosa (P. aeruginosa) strain is proposed. The PD model we hav

Pharmacokinetic–pharmacodynamic modeling
✍ Takayuki Katsube; Yoshitaka Yano; Yoshinori Yamano; Tadashi Munekage; Naomi Kuro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to explain the data from an in vitro dynamic model is proposed. Two carbapenem antibiotics, doripenem and meropenem, and three Pseudomonas aeruginosa strains were used as example drugs and strains. The PD model we originally developed to